News

Oxalys Pharmaceuticals

Oxalys is developing drugs for neurodegenerative disease. We are a startup that spun out of MIT in 2011. Our first product will treat Huntington’s disease (HD)

Continue reading

2016 InBIA Accelerator Program of the Year Award goes to The Canadian Technology Accelerator in Boston (CTA@Boston)

Published by Rachele RyanPictured (L-R): Consul General David Alward, Christina Pomanski, Rachele Ryan, Erin Donahue, Christine Sarkisian, Senior Trade Commissioner Thierry Weissenburger, Christine Carr, Susan Ahern, & Hendrik Kuipers. The Canadian Technology Accelerator in Boston (CTA@Boston), has been awarded the International Business Innovation Association’s (InBIA) 2016 Accelerator Program of the Year Award. It was judged along with… Read…

Continue reading